| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |